GLP-1 Treatments

A new clinical analysis suggests that orforglipron, Eli Lilly’s first GLP-1 weight-loss pill, may become a strong alternative to weekly injections like Wegovy and Mounjaro. The findings come from the latest GLP-1 study 2025, where researchers reported meaningful reductions in body weight, improved blood sugar control, and benefits for adults living with type 2 diabetes …

Thinking about stopping Mounjaro (tirzepatide) can feel a bit unsettling. You’ve worked hard to lose weight, built new habits, and you don’t want everything to slip back the moment the injections stop. The good news is that coming off Mounjaro can be safe, steady and manageable when you understand what your body does next and …